Should People With Immune Problems Get Third Vaccine Doses?
The New York Times
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
When it came to coronavirus vaccination, the third time was the charm for Esther Jones, a dialysis nurse in rural Oregon. After two doses of the Pfizer-BioNTech vaccine failed to jolt her immune system into producing antibodies, she sought out a third, this time the Moderna shot. It worked. Blood tests revealed a reasonable antibody response, although lower than what would be detected in healthy people. She received a fourth dose last month in hopes of boosting the levels even more. Ms. Jones, 45, had a kidney transplant in 2010. To prevent rejection of the organ, she has taken drugs that suppress the immune response ever since. She expected to have trouble responding to a coronavirus vaccine, and enrolled in one of the few studies so far to test the utility of a third dose in people with weak immune systems.
The findings showed the highest mortality occurred among infants who were Black, lived in Southern states or had fetal birth defects.
As Lanzhou beef noodle soup goes from regional specialty to global attraction, I set out to find the best bowls in New York City.
As of Tuesday, 22 children and two adults had been infected, all of whom were unvaccinated, local officials said.
It’s the most energetic particle of its kind ever discovered, and scientists have no idea where it came from.
This 30-minute recipe for “Marry Me Salmon” feels special but is easy enough for a weeknight.
The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 years later, she’s pursuing new research on the boundaries of life.
Once thought of as a byproduct of collard greens, brothy, complex potlikker takes on new life as a wonderful base for a Japanese staple.
The new research adds to the mysteries of the planet’s deepest interior region.
The billionaire is leading a group of investors in the unsolicited offer, which complicates the start-up’s plan to raise more money.
At cardiology conferences and diabetes meetings, doctors can’t help noticing that thin seems to be very in.
President Trump’s executive order is altering scientific exploration across a broad swath of fields, even beyond government agencies, researchers say.
After helping President Trump get elected, Elon Musk was poised to dominate the country’s A.I. policies. Then Mr. Altman sneaked into the White House.
Shock and grief rippled through the health community as lifelines for care were abruptly severed.